Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BY 4.0Frontiers in Public Health

Regulation of medical artificial intelligence in public health: governance lessons and implications for China

  • Jiayun Zhao1
  • Qing Chen1
  1. 1School of Health Economics and Management, Nanjing University of Chinese Medicine
Open at sourceDOICite

Abstract

With the deep integration of artificial intelligence (AI) technologies into public health and clinical care, challenges including dynamic algorithm iteration, data security risks, and ambiguous liability allocation pose multifaceted threats to traditional regulatory frameworks. Among these challenges, this study focuses specifically on the tension between static pre-market approval and the continuous iteration of AI-enabled medical systems. Globally, the European Union (EU), the United States (US), and Japan have developed distinct regulatory models that offer valuable lessons for China. This paper conducts a comparative analysis of medical AI regulatory logics and institutional practices across jurisdictions, with particular attention to algorithm modification, lifecycle oversight, and continuous post-market evaluation. Building on international experience, we propose an optimized institutional pathway for China that centers on differentiated algorithm-change control, continuous lifecycle evaluation, and risk-based regulatory adjustment, while treating liability allocation, risk classification, and data governance as supporting dimensions. This framework provides theoretical support and practical guidance for improving China's medical AI regulatory system, promoting standardized technology development, and supporting the orderly development of public health services in the digital health era.

Related

  1. Balancing innovation and ethics: responsible governance of artificial intelligence hallucinations in healthcare.
    Meixin Du, Ni Zhan
    Philosophy, ethics, and humanities in medicine : PEHMPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC
  2. Characteristics and structural imbalances of biomedical academicians in China: policy implications for the governance of leading medical talents
    Rong Liu, De Fei Huang, Tao Huang +1
    Frontiers in Public HealthPeer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefDOAJ
  3. Human–artificial intelligence collaboration in emergency medical services: from diagnostic algorithms to shared decision support
    Hang A Park
    Clinical and experimental emergency medicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Predictors of Intentions to Learn and Adopt Medical Artificial Intelligence Among Healthcare Professionals in Ghana: A Descriptive Cross‐Sectional Study
    Godwin Adzakpah, Daniel Kwame Kwansah Quansah, Mavis Puopelle Dakorah +10
    Health science reportsPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. A Tale of Two Countries: Challenges in the Adoption of Artificial Intelligence in Medical Imaging in India and Singapore.
    Charlene Jin Yee Liew, Swati Goyal
    The Indian journal of radiology & imagingPeer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMC

Cite

BibTeXRIS
BibTeX
@article{zhao2026regulation,
  title = {{Regulation of medical artificial intelligence in public health: governance lessons and implications for China}},
  author = {Jiayun Zhao and Qing Chen},
  journal = {Frontiers in Public Health},
  year = {2026},
  month = oct,
  doi = {10.3389/fpubh.2026.1962331},
  url = {https://www.frontiersin.org/articles/10.3389/fpubh.2026.1962331/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Regulation of medical artificial intelligence in public health: governance lessons and implications for China
AU  - Jiayun Zhao
AU  - Qing Chen
PY  - 2026
DA  - 2026/10/29
JO  - Frontiers in Public Health
DO  - 10.3389/fpubh.2026.1962331
UR  - https://www.frontiersin.org/articles/10.3389/fpubh.2026.1962331/full
AB  - With the deep integration of artificial intelligence (AI) technologies into public health and clinical care, challenges including dynamic algorithm iteration, data security risks, and ambiguous liability allocation pose multifaceted threats to traditional regulatory frameworks. Among these challenges, this study focuses specifically on the tension between static pre-market approval and the continuous iteration of AI-enabled medical systems. Globally, the European Union (EU), the United States (US), and Japan have developed distinct regulatory models that offer valuable lessons for China. This paper conducts a comparative analysis of medical AI regulatory logics and institutional practices across jurisdictions, with particular attention to algorithm modification, lifecycle oversight, and continuous post-market evaluation. Building on international experience, we propose an optimized institutional pathway for China that centers on differentiated algorithm-change control, continuous lifecycle evaluation, and risk-based regulatory adjustment, while treating liability allocation, risk classification, and data governance as supporting dimensions. This framework provides theoretical support and practical guidance for improving China's medical AI regulatory system, promoting standardized technology development, and supporting the orderly development of public health services in the digital health era.
SN  - 2296-2565
ER  -